These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8385970

  • 21. Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
    Leyvraz S, Perey L, Rosti G, Lange A, Pampallona S, Peters R, Humblet Y, Bosquée L, Pasini F, Marangolo M.
    J Clin Oncol; 1999 Nov; 17(11):3531-9. PubMed ID: 10550151
    [Abstract] [Full Text] [Related]

  • 22. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
    Bunn PA, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR.
    J Clin Oncol; 1995 Jul; 13(7):1632-41. PubMed ID: 7602352
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF.
    Ford PA, Arbuck SG, Minniti C, Miller LL, DeMaria D, O'Dwyer PJ.
    Eur J Cancer; 1996 Apr; 32A(4):631-5. PubMed ID: 8695266
    [Abstract] [Full Text] [Related]

  • 28. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
    Oshita F, Kasai T, Kurata T, Fukuda M, Yamamoto N, Ohe Y, Tamura T, Eguchi K, Shinkai T, Saijo N.
    Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
    [Abstract] [Full Text] [Related]

  • 29. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
    Krigel RL, Palackdharry CS, Padavic K, Haas N, Kilpatrick D, Langer C, Comis R.
    J Clin Oncol; 1994 Jun; 12(6):1251-8. PubMed ID: 8201386
    [Abstract] [Full Text] [Related]

  • 30. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
    Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI, Gazdar AF, Edison M, Phelps RM, Lesar M, Phares JC.
    J Clin Oncol; 1994 Oct; 12(10):2022-34. PubMed ID: 7931470
    [Abstract] [Full Text] [Related]

  • 31. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ, Doroshow JH, Venkataraman K, Chang K, Raschko J, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Margolin K, Forman S, Akman S, Coluzzi P, Ahn C, Weiss L, Gadgil U, Harrison J.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [Abstract] [Full Text] [Related]

  • 32. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
    Livingston RB, Crowley JJ, Thompson T, Williamson SK, Meyers FJ, O'Rourke T, Neefe JR.
    Cancer; 1993 Jun 01; 71(11):3509-13. PubMed ID: 8387881
    [Abstract] [Full Text] [Related]

  • 33. High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
    Johnson DH, DeLeo MJ, Hande KR, Wolff SN, Hainsworth JD, Greco FA.
    J Clin Oncol; 1987 May 01; 5(5):703-9. PubMed ID: 3033161
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
    Gómez H, Mas L, Casanova L, Pen DL, Santillana S, Valdivia S, Otero J, Rodriguez W, Carracedo C, Vallejos C.
    J Clin Oncol; 1998 Jul 01; 16(7):2352-8. PubMed ID: 9667250
    [Abstract] [Full Text] [Related]

  • 36. Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer.
    Vigani A, Pensa F, Vaira F, Bancalari L, Cordani S, Maggiani R, Canessa P, Pronzato P.
    Anticancer Res; 2000 Jul 01; 20(5C):4015-8. PubMed ID: 11268494
    [Abstract] [Full Text] [Related]

  • 37. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F, Santo A, Cellerino R.
    Cancer; 1997 Dec 15; 80(12):2222-9. PubMed ID: 9404698
    [Abstract] [Full Text] [Related]

  • 38. Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.
    Aisner J, Whitacre MY, Budman DR, Propert K, Strauss G, Van Echo DA, Perry M.
    Cancer Chemother Pharmacol; 1992 Dec 15; 29(6):435-8. PubMed ID: 1314712
    [Abstract] [Full Text] [Related]

  • 39. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
    Riccardi A, Gobbi P, Danova M, Giordano M, Pieresca C, Bertoloni D, Brugnatelli S, Ascari E.
    Haematologica; 1993 Dec 15; 78(1):44-8. PubMed ID: 7684012
    [Abstract] [Full Text] [Related]

  • 40. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Kamei H, Horiguchi T, Kodani T, Maeda T, Tabata M, Shibayama T.
    Cancer; 1993 Sep 01; 72(5):1597-601. PubMed ID: 8394202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.